Clinical characteristics of medication-overuse headache according to the class of acute medication: A cross-sectional multicenter study
- PMID: 35833500
- DOI: 10.1111/head.14363
Clinical characteristics of medication-overuse headache according to the class of acute medication: A cross-sectional multicenter study
Abstract
Objective: To characterize the clinical features of patients with medication-overuse headache (MOH) according to the class of acute medications being overused.
Background: MOH is a common global health problem, severely disabling the majority of the patients affected. Although various medications can cause MOH, whether clinical features differ according to the overused medication type remains unclear.
Methods: We analyzed data from a multicenter cross-sectional study in neurology clinics in Korea from April 2020 to June 2021.
Results: Among 229 eligible patients, MOH was documented in patients who overused multiple drug classes (69/229, 30.1%; most frequent occurrence), triptans (50/229, 21.8%), non-opioid analgesics (48/229, 21.0%), and combination-analgesics (40/229, 17.4%). Patients who overused multiple drug classes reported more frequent use of acute medications (median [25th-75th percentiles]: 25.0 [15.0-30.0] vs. 17.5 [10.0-25.5] days/month, p = 0.029) and fewer crystal-clear days (0.0 [0.0-9.5] vs. 9.0 [0.0-10.0] days/month, p = 0.048) than those who overused triptans. Patients who overused multiple drug classes also reported shorter intervals from chronic daily headache to the onset of MOH than patients who overused combination-analgesics (0.6 [0.2-1.9] vs. 2.4 [0.7-5.4] years, p = 0.001) or non-opioid analgesics (1.5 [0.6-4.3] years, p = 0.004). Patients who overused multiple drug classes reported more emergency room visits (1.0 [0.0-1.0] visits/year) than those who overused combination-analgesics (0.0 [0.0-1.0], p = 0.024) or non-opioid analgesics (0.0 [0.0-1.0], p = 0.030). Patients who overused triptans reported fewer headache days (21.0 [20.0-30.0] vs. 30.0 [20.5-30.0] days/month, p = 0.008) and fewer severe headache days (7.0 [4.0-10.0] vs. 10.0 [5.0-15.0] days/month, p = 0.017) than those who overused non-opioid analgesics.
Conclusions: Some clinical characteristics of MOH significantly differed according to the class of overused medications. The findings from this study may contribute to the understanding of the clinical characteristics and pathophysiology of MOH.
Keywords: chronic daily headache; ergotamine; medication-overuse headache; migraine; non-opioid analgesics; triptans.
© 2022 American Headache Society.
Similar articles
-
Three-month treatment outcome of medication-overuse headache according to classes of overused medications, use of acute medications, and preventive treatments.Sci Rep. 2024 Jul 11;14(1):16013. doi: 10.1038/s41598-024-66906-0. Sci Rep. 2024. PMID: 38992145 Free PMC article.
-
Behavioral dependence in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria.Headache. 2008 Jul;48(7):1026-36. doi: 10.1111/j.1526-4610.2007.00999.x. Epub 2007 Dec 11. Headache. 2008. PMID: 18081820
-
Medication overuse headache in Europe and Latin America: general demographic and clinical characteristics, referral pathways and national distribution of painkillers in a descriptive, multinational, multicenter study.J Headache Pain. 2015;17:20. doi: 10.1186/s10194-016-0612-2. Epub 2016 Mar 8. J Headache Pain. 2015. PMID: 26957090 Free PMC article.
-
Medication-overuse headache.Continuum (Minneap Minn). 2012 Aug;18(4):807-22. doi: 10.1212/01.CON.0000418644.32032.7b. Continuum (Minneap Minn). 2012. PMID: 22868543 Review.
-
Comparing Two Ways to Manage Symptoms for Patients Who Have Chronic Migraine and Frequent Medication Use – The MOTS Trial [Internet].Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2022 Feb. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2022 Feb. PMID: 39432696 Free Books & Documents. Review.
Cited by
-
Three-month treatment outcome of medication-overuse headache according to classes of overused medications, use of acute medications, and preventive treatments.Sci Rep. 2024 Jul 11;14(1):16013. doi: 10.1038/s41598-024-66906-0. Sci Rep. 2024. PMID: 38992145 Free PMC article.
-
Critical reflections on medication overuse headache in patients with migraine: An unsolved riddle in nociception.Neurobiol Pain. 2025 Feb 9;17:100179. doi: 10.1016/j.ynpai.2025.100179. eCollection 2025 Jan-Jun. Neurobiol Pain. 2025. PMID: 40040782 Free PMC article. Review.
-
Activation of the microglial P2X7R/NLRP3 inflammasome mediates central sensitization in a mouse model of medication overuse headache.Front Mol Neurosci. 2023 Jun 12;16:1177171. doi: 10.3389/fnmol.2023.1177171. eCollection 2023. Front Mol Neurosci. 2023. PMID: 37377770 Free PMC article.
References
REFERENCES
-
- Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38:1-211.
-
- Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol. 2004;3:475-483.
-
- Westergaard ML, Glümer C, Hansen EH, Jensen RH. Prevalence of chronic headache with and without medication overuse: associations with socioeconomic position and physical and mental health status. Pain. 2014;155:2005-2013.
-
- Westergaard ML, Hansen EH, Glümer C, Olesen J, Jensen RH. Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review. Cephalalgia. 2014;34:409-425.
-
- Granella F, Farina S, Malferrari G, Manzoni GC. Drug abuse in chronic headache: a clinico-epidemiologic study. Cephalalgia. 1987;7:15-19.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous